IGM Biosciences, Inc. Operating Cash Flow
IGM Biosciences, Inc. reported Operating Cash Flow of -$83.31 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-07-31
- IGM Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$50.79M.
- IGM Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$32.52M.
- IGM Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$34.82M.
- IGM Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$38.38M.
- IGM Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$153.00M.
- IGM Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$192.23M.
- IGM Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$5.85M.
- IGM Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$124.98M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | -$50.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$83.31M 10-Q · filed 2025-07-31 | -$118.13M derived: sum of 3 quarters · filed 2025-07-31 | -$156.51M derived: sum of 4 quarters · filed 2025-07-31 | ||||
| 2025-03-31 | -$32.52M 10-Q · filed 2025-05-13 | -$67.34M derived: sum of 2 quarters · filed 2025-05-13 | -$105.72M derived: sum of 3 quarters · filed 2025-05-13 | -$143.10M derived: sum of 4 quarters · filed 2025-07-31 | ||||
| 2024-12-31 | -$34.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$73.20M derived: sum of 2 quarters · filed 2025-03-06 | -$110.58M derived: sum of 3 quarters · filed 2025-07-31 | -$153.00M 10-K · filed 2025-03-06 | ||||
| 2024-09-30 | -$38.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$75.76M derived: sum of 2 quarters · filed 2025-07-31 | -$118.18M 10-Q · filed 2024-11-08 | -$166.18M derived: sum of 4 quarters · filed 2025-07-31 | ||||
| 2024-06-30 | -$37.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$79.79M 10-Q · filed 2025-07-31 | -$127.80M derived: sum of 3 quarters · filed 2025-07-31 | -$167.92M derived: sum of 4 quarters · filed 2025-07-31 | ||||
| 2024-03-31 | -$42.42M 10-Q · filed 2025-05-13 | -$90.42M derived: sum of 2 quarters · filed 2025-05-13 | -$130.55M derived: sum of 3 quarters · filed 2025-05-13 | -$183.65M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$48.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$88.13M derived: sum of 2 quarters · filed 2025-03-06 | -$141.23M derived: sum of 3 quarters · filed 2025-03-06 | -$192.23M 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | -$40.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$93.23M derived: sum of 2 quarters · filed 2024-11-08 | -$144.22M 10-Q · filed 2024-11-08 | -$182.08M derived: sum of 4 quarters · filed 2025-03-06 | ||||
| 2023-06-30 | -$53.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$104.10M 10-Q · filed 2024-08-14 | -$141.96M derived: sum of 3 quarters · filed 2025-03-06 | -$182.37M derived: sum of 4 quarters · filed 2025-03-06 | ||||
| 2023-03-31 | -$51.00M 10-Q · filed 2024-05-08 | -$88.86M derived: sum of 2 quarters · filed 2025-03-06 | -$129.27M derived: sum of 3 quarters · filed 2025-03-06 | -$17.96M derived: sum of 4 quarters · filed 2025-03-06 | ||||
| 2022-12-31 | -$37.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$78.27M derived: sum of 2 quarters · filed 2025-03-06 | $33.04M derived: sum of 3 quarters · filed 2025-03-06 | -$5.85M 10-K · filed 2025-03-06 | ||||
| 2022-09-30 | -$40.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $70.89M derived: sum of 2 quarters · filed 2023-11-13 | $32.01M 10-Q · filed 2023-11-13 | -$3.29M derived: sum of 4 quarters · filed 2024-03-07 | ||||
| 2022-06-30 | $111.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $72.42M 10-Q · filed 2023-08-03 | $37.12M derived: sum of 3 quarters · filed 2024-03-07 | $2.71M derived: sum of 4 quarters · filed 2024-03-07 | ||||
| 2022-03-31 | -$38.89M 10-Q · filed 2023-05-12 | -$38.87M 10-Q · filed 2022-05-09 | -$74.19M derived: sum of 2 quarters · filed 2024-03-07 | -$108.59M derived: sum of 3 quarters · filed 2024-03-07 | -$135.61M derived: sum of 4 quarters · filed 2024-03-07 | |||
| 2021-12-31 | -$35.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$69.71M derived: sum of 2 quarters · filed 2024-03-07 | -$96.72M derived: sum of 3 quarters · filed 2024-03-07 | -$124.98M 10-K · filed 2024-03-07 | -$124.34M 10-K · filed 2022-03-29 | |||
| 2021-09-30 | -$34.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$61.42M derived: sum of 2 quarters · filed 2022-11-03 | -$89.68M 10-Q · filed 2022-11-03 | -$89.43M 10-Q · filed 2021-11-04 | -$113.02M derived: sum of 4 quarters · filed 2023-03-30 | |||
| 2021-06-30 | -$27.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$55.28M 10-Q · filed 2022-08-08 | -$54.61M 10-Q · filed 2021-08-09 | -$78.62M derived: sum of 3 quarters · filed 2023-03-30 | -$93.69M derived: sum of 4 quarters · filed 2023-03-30 | |||
| 2021-03-31 | -$28.26M 10-Q · filed 2022-05-09 | -$51.60M derived: sum of 2 quarters · filed 2023-03-30 | -$66.68M derived: sum of 3 quarters · filed 2023-03-30 | -$79.76M derived: sum of 4 quarters · filed 2023-03-30 | ||||
| 2020-12-31 | -$23.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$38.42M derived: sum of 2 quarters · filed 2023-03-30 | -$51.49M derived: sum of 3 quarters · filed 2023-03-30 | -$67.88M 10-K · filed 2023-03-30 | -$67.30M 10-K · filed 2021-03-30 | |||
| 2020-09-30 | -$15.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$28.15M derived: sum of 2 quarters · filed 2021-11-04 | -$44.54M 10-Q · filed 2021-11-04 | -$56.61M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2020-06-30 | -$13.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$29.46M 10-Q · filed 2021-08-09 | -$41.53M derived: sum of 3 quarters · filed 2022-03-29 | -$56.91M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2020-03-31 | -$16.39M 10-Q · filed 2021-05-06 | -$28.45M derived: sum of 2 quarters · filed 2022-03-29 | -$43.83M derived: sum of 3 quarters · filed 2022-03-29 | -$53.16M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2019-12-31 | -$12.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$27.45M derived: sum of 2 quarters · filed 2022-03-29 | -$36.77M derived: sum of 3 quarters · filed 2022-03-29 | -$45.12M 10-K · filed 2022-03-29 | ||||
| 2019-09-30 | -$15.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$24.70M derived: sum of 2 quarters · filed 2020-11-05 | -$33.05M 10-Q · filed 2020-11-05 | -$39.24M derived: sum of 4 quarters · filed 2021-03-30 | ||||
| 2019-06-30 | -$9.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$17.67M 10-Q · filed 2020-08-06 | -$23.86M derived: sum of 3 quarters · filed 2021-03-30 | |||||
| 2019-03-31 | -$8.35M 10-Q · filed 2020-05-07 | -$14.54M derived: sum of 2 quarters · filed 2021-03-30 | ||||||
| 2018-12-31 | -$6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$20.04M 10-K · filed 2021-03-30 | ||||||
| 2018-09-30 | -$13.85M 10-Q · filed 2019-11-07 | |||||||
| 2017-12-31 | -$10.36M 10-K · filed 2020-03-26 |